MiniMed Group closed at $19.57 on Nov 4, up 3.79%, 13.0% below its highest close since Sep 11. Volume of 5.4M shares was 0.32× its 20-day average (below normal).
Split-adjusted performance: -0.4% over one month.
In the quarter ended Jul 31, 2026, revenue was $843M, with a net margin of 0.0%.
Short interest was 20.7M shares at the Oct 15 settlement, up 13.8% from the prior report (7.4% of float, 1.0 days to cover).
No reported quarters with price history yet.
Percentile among 110 companies (100 = best)
Industry medians: 6-month return −4.4%, revenue growth +8.9%, net margin −8.2%, P/E 29.7×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| MMEDMiniMed Group | $19.57 | +3.79% | — | — | 0.0% | — | $5.50B | |
| MMSIMerit Medical Systems | $90.67 | +7.74% | +47.1% | +8.4% | 10.2% | 33.9 | $5.43B | Compare |
| HAEHaemonetics | $126.95 | +5.55% | +141.0% | +5.6% | 9.7% | 60.0 | $5.78B | Compare |
| HTFLHeartflow | $56.31 | +3.51% | +85.9% | — | −24.6% | — | $4.90B | Compare |
| TFXTeleflex Incorporated | $147.68 | +5.52% | +19.8% | +28.9% | 17.5% | — | $6.26B | Compare |
| IRTCiRhythm Holdings | $136.47 | +7.99% | +15.9% | +20.1% | −0.2% | — | $4.50B | Compare |
| ICUIICU Medical | $174.50 | +7.83% | +45.9% | +0.5% | 3.5% | 145.0 | $4.36B | Compare |
| PLSEPulse Biosciences, Inc Common Stock (DE) | $57.25 | +9.67% | +198.0% | — | −5681.3% | — | $4.08B | Compare |
| ATRCAtriCure | $64.48 | +6.74% | +130.2% | +12.8% | 5.8% | 310.8 | $3.28B | Compare |
No recent articles focused on MiniMed Group. 3 articles mention it in passing.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
